Acyl-CoA dehydrogenases (ACDs) are FAD-dependent enzymes that
catalyze the conversion of an
appropriate fatty acyl-CoA thioester substrate to the corresponding
trans-α,β-enoyl-CoA product. Early
studies
have shown that the dehydrogenation is stereospecific and is initiated
by the abstraction of the pro-R
α-H,
followed by the transfer of the pro-R β-H, as a
hydride equivalent, to the bound FAD. However, recent
studies of the inactivation of ACDs by a metabolite of hypoglycin A,
(methylenecyclopropyl)acetyl-CoA
(MCPA-CoA), led to an alternative mechanism in which the reducing
equivalent is delivered from the initially
formed α-anion to the bound FAD via a single electron transfer
process. To further explore the observed
mechanistic discrepancy, we have reexamined the inhibitory properties
of a closely related MCPA-CoA analogue,
spiropentylacetyl-CoA (SPA-CoA), which was previously reported as a
tight-binding inhibitor for ACDs. In
contrast to early results, our data showed that SPA-CoA is a
mechanism-based inhibitor for pig kidney medium-chain acyl-CoA dehydrogenase (MCAD) and Megasphaera elsdenii
short-chain acyl-CoA dehydrogenase
(SCAD) and that the inactivation is time-dependent,
active-site-directed, and irreversible. More
importantly,
both (R)- and (S)-SPA-CoA could effectively
inactivate MCAD, and the resulting inhibitor−FAD adducts
appear to have one of the three-membered rings of the spiropentyl
moiety cleaved. Since the inactivation is
nonstereospecific with respect to Cβ−C bond scission,
the ring opening of SPA-CoA leading to enzyme
inactivation is likely initiated by a spiropentylcarbinyl radical.
Such a radical-induced ring fragmentation is
expected to be extremely facile and may bypass the chiral
discrimination normally imposed by the enzyme.
Thus, these results are consistent with our early notion that MCAD
is capable of mediating one-electron redox
chemistry. Interestingly, it was also found that
(R)-SPA-CoA is an irreversible inhibitor for SCAD, while
the
S-epimer is only a competitive inhibitor for the same
enzyme. The selective inhibition exhibited by these
compounds against two closely related dehydrogenases is likely a
consequence of the distinct steric and electronic
demands imposed by the active sites of MCAD and SCAD. Such
information is important for the design of
novel class-selective inhibitors to control and/or regulate fatty acid
metabolism.